Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy

Int J Cardiol

12 July Jul 2021 4 years ago
  • Muscogiuri G, Fusini L, Sicuso R, Guglielmo M, Baggiano A, Mushtaq S, Conte E, Annoni A, Formenti A, Mancini ME, , Andreini D, Tondo C, Pepi M, Sommariva E, Pontone G
QR Code

We aim to evaluate the value of Cardiac magnetic resonance (CMR) feature tracking (CMR-FT) in addition to Task Force Criteria(TFC) in patients with (arrhythmogenic cardiomyopathy) AC biopsy-proved.

Reference

Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy. Muscogiuri G, Fusini L, Ricci F, Sicuso R, Guglielmo M, Baggiano A, Gasperetti A, Casella M, Mushtaq S, Conte E, Annoni A, Formenti A, Mancini ME, Babbaro M, Mollace R, Collevecchio A, Scafuri S, Kukavica D, Andreini D, Basso C, Rizzo S, De Gaspari M, Priori S, Dello Russo A, Tondo C, Pepi M, Sommariva E, Rabbat M, Guaricci AI, Pontone G. Int J Cardiol. 2021 Jul 6:S0167-5273(21)01090-1. doi: 10.1016/j.ijcard.2021.06.052

Go to PubMed